Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  V.TLT.WT | TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Bullboard Posts
Comment by macman1519on Mar 28, 2018 9:16am
83 Views
Post# 27793114

RE:RE:Cannabinoid

RE:RE:Cannabinoid
Jjm, the more people explain this, the smellier it gets. Instead of asking for one bid from anyone, tlt ignores previous successes, that show 100% kill rate, and decides to go with a weed experiment that gets 35% kill rate. 
then we crow about it, and say that is the direction we are going. Screw the 100%, 3 5% , looks better????? 
Is that about right?  You are right, jjm, the terms better be good!!!! All the choir last two days have been minimizing agan, the old, wait 2 or 4 years, macer and bbbhenny have been doing each other with glee, knocking down our phase 1 efficacy. The pp pushers are trying their hardest to soft bash tlt.
Personally, a bidding war would have been cleaner. 
Going to give the good doctor the benefit of the doubt, that he is trying to protect our science as long as he can, but
 Terms better be good!! 

enriquesuave wrote: The 10% efficacy was just because they brought down he concentration of TLD-1433 real low in order to evaluate the synergistic effect of both.  If they had kept it higher then it alone would have caused100%  destruction and no way to know effect of cannabinoid. So maybe they can used about 1/3 -1/2 of the intended dose of TLD-1433 when combined in order to get full 100% effect.  A much safer dose all together.IMHO


jojomarch wrote: So let me get this straight , 2 weeks ago we are told that our lead compound is destroying tumors and brain cancer stem cells . Then yesterday they tell us only 10 % efficacy but  " lo and behold " combined with cannabinoid this new milkshake is 35% efficient wich is 5% greater than what is considered the pass line for commercialization at the FDA . All this happens when  TLT is in need  of capital and " lo and behold " the cannabis company is flush with cash . I wish I had timing like that . The terms better be good . 

GO TLT GO 

GO AM GO 

GO JV GO 

GO CANNA PHARMA  GO

HAPPY WEDNESDAY 




Bullboard Posts